98%
921
2 minutes
20
Background And Aims: Suture dehiscence and gastric sleeve dilation can cause post-endoscopic sleeve gastroplasty (ESG) weight regain. To our knowledge, gastroplasty with endoscopic myotomy (GEM) as a post-ESG revision technique has not been previously reported. We present a case of GEM successfully used after a primary ESG as a revision procedure.
Methods: A 52-year-old man had a weight of 111 kg in 2016 before ESG. Postprocedure, his weight reached 95 kg. However, he returned in 2023 with weight regain to 121 kg. GEM was decided after multidisciplinary discussion. Previous suture sites were appreciated. An antral myotomy was started with a bleb injected 8 cm proximal to the pylorus. The submucosal tunnel was entered by hybrid knife incision and dissected 2 cm before the pylorus. A partial full-thickness myotomy was performed with lysis of significant submucosal fibrosis. Gastroplasty was performed, and 8 suture bites were placed in a running modified "U" pattern to decrease gastric volume.
Results: There were no intraprocedure adverse events. At 3-month follow-up, the patient had lost 11 kg, and at 1-year follow-up, he had lost 20 kg.
Conclusions: To our knowledge, GEM as a post-ESG revision has not been previously reported. Our case suggests that a post-ESG revision GEM with a modified "U" suturing pattern is feasible.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12282414 | PMC |
http://dx.doi.org/10.1016/j.vgie.2025.03.038 | DOI Listing |
J Metab Bariatr Surg
August 2025
Department of Surgical Gastroenterology, Pace Hospitals, Hyderabad, India.
Obesity affects about 39% of the global population, and bariatric surgery is a leading treatment option. As the number of primary bariatric procedures increases, so does the demand for revisional bariatric surgeries (RBSs), which are often more complex and associated with increased risks of complications. This case report details an unusual complication of RBS that surgeons should be aware of.
View Article and Find Full Text PDFJ Metab Bariatr Surg
August 2025
Division of Gastrointestinal Surgery, Department of Surgery, Seoul National University Hospital, Seoul, Korea.
Prader-Willi Syndrome (PWS) is a genetic disorder characterized by insatiable hyperphagia, resulting in severe, early-onset obesity that is often refractory to conventional management. The associated comorbidities and reduced life expectancy in PWS present a significant therapeutic challenge. This review synthesizes the existing literature on the controversial role, outcomes, and complexities of bariatric surgery in patients with PWS.
View Article and Find Full Text PDFInt Med Case Rep J
August 2025
Department of Neurology, Chongzhou People's Hospital, Sichuan, People's Republic of China.
Fluoroacetamide, a commonly used convulsant rodenticide, can rapidly damage the nervous, digestive, and cardiovascular systems, potentially leading to fatal outcomes if ingested. This study reports the case of a 62-year-old Chinese woman who presented with symptoms of intoxication, including slurred speech, agitation, and seizure-like episodes, accompanied by gastrointestinal symptoms such as vomiting, skin bruising, and mild liver dysfunction. Toxin analysis revealed the presence of fluoroacetate in her blood and urine, and diffusion weighted imaging (DWI) imaging indicated white matter lesions, leading to the diagnosis of rare fluoroacetamide poisoning.
View Article and Find Full Text PDFAm J Case Rep
September 2025
Department of Orthopedic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
BACKGROUND The treatment of nonunion with deformity and shortening remains a significant challenge in orthopedic surgery. The chipping and lengthening technique is used for bone reconstruction and new bone formation, without the need for bone grafting. However, inadequate bone regeneration can require additional treatment.
View Article and Find Full Text PDFObes Surg
September 2025
Department of Minimally Invasive Digestive Surgery, Antoine Béclère Hospital, AP-HP, 157 Rue de La Porte de Trivaux, 92141 Clamart, Clamart, France.
Background: Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain. Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes. This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS.
View Article and Find Full Text PDF